Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

NCT01520337 is registered in ClinicalTrials.gov with Cosmo Technologies Ltd as lead sponsor.

NCT NCT01520337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01520337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy
Lead sponsor
Cosmo Technologies Ltd
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
October 31, 2013
Enrollment
170 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

polyp and adenoma detection during colonoscopy